Multimodal Noninvasive Assessment of Peripheral Circulation in Chronic Limb-threatening Ischemia
NCT ID: NCT05786001
Last Updated: 2024-06-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2024-06-17
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CCTA-based Coronary Plaque Characterization and High-sensitive Troponin T for the Prediction of Cardiovascular Outcomes
NCT02030704
Multimodal Imaging Assessment After Revascularization in Patients With Acute Myocardial Infarction
NCT07130409
Quantitative Perfusion Imaging Using Contrast Enhanced Perfusion Ultrasound, MRI and Perfusion Angiography
NCT06103708
Intracoronary Thrombus Detection by Magnetic Resonance Imaging
NCT02776657
SPECT/CT Imaging of Skeletal Muscle Perfusion
NCT02791204
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Unhealthy group
Individuals with CLTI
No interventions assigned to this group
Age control group
Healthy individuals over the age of 50
No interventions assigned to this group
Healthy group
Healthy and young individuals
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* for age control group age \>50 and not diagnosed with cardiovascular diseases. 0.9 \< ABI \< 1.3
* for healthy group 18 \<= age \<= 50 and no history of cardiovascular disease
* volunteering for study
Exclusion Criteria
* denial
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University Hospital
OTHER
Tampere University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Niku Oksala
Prof, MD, PhD, DSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Niku Oksala, MD, PhD, DSc
Role: PRINCIPAL_INVESTIGATOR
Tampere University, Tampere University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tampere University
Tampere, Pirkanmaa, Finland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R20156L
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.